Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Fujimoto

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
JCI Insight|October 25, 2022
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cellsYuta Yamaguchi, Yasuhiro Kato, Ryuya Edahiro, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer DrugKenichiro Shimokawa, Koji Ono, Moriteru Asano, et al.
Science Immunology|March 31, 2023
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complexTaiichiro Shirai, Akiko Nakai, Emiko Ando, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications|June 17, 2025
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosisHiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Lancet Regional Health. Western Pacific|December 26, 2022
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in JapanYuta Yamaguchi, Shinichiro Nameki, Yasuhiro Kato, et al.
JCI Insight|October 25, 2022
Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cellsYuta Yamaguchi, Yasuhiro Kato, Ryuya Edahiro, et al.
ACS Medicinal Chemistry Letters|July 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer DrugKenichiro Shimokawa, Koji Ono, Moriteru Asano, et al.
Science Immunology|March 31, 2023
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complexTaiichiro Shirai, Akiko Nakai, Emiko Ando, et al.
Bioorganic & Medicinal Chemistry|September 5, 2014
Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonistsTomoaki Hasui, Norio Ohyabu, Taiichi Ohra, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Nature Communications|June 17, 2025
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosisHiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, et al.
Pageof 3